Therapeutic Uses
Anti-Parkinsons
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
DL-Carbidopa is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
DL-Carbidopa usage and description
DL-Carbidopa is a drug that is commonly used in the treatment of Parkinson's disease. It is a chemical compound that is structurally similar to the amino acid tyrosine. DL-Carbidopa works by inhibiting the activity of the enzyme DOPA decarboxylase, which is responsible for the breakdown of levodopa in the peripheral nervous system. This results in increased levels of levodopa in the brain, which improves the symptoms of Parkinson's disease.
DL-Carbidopa is typically administered orally in combination with levodopa. This combination is known as carbidopa-levodopa or Sinemet. DL-Carbidopa is not effective on its own and must be used in combination with levodopa to be effective.
The chemical formula of DL-Carbidopa is C10H14N2O4. It is a white, crystalline powder that is soluble in water. The drug is typically available in tablet form and is taken orally.
DL-Carbidopa is generally well-tolerated, but like any medication, it can cause side effects. The most common side effects of DL-Carbidopa include nausea, vomiting, loss of appetite, and diarrhea. In rare cases, DL-Carbidopa can cause more serious side effects such as hallucinations, confusion, and difficulty breathing. It is important to talk to a healthcare provider if you experience any side effects while taking DL-Carbidopa.
